These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5434719)

  • 21. Adverse effects of antituberculosis drugs.
    Girling DJ
    Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920
    [No Abstract]   [Full Text] [Related]  

  • 22. [Morphological changes in the bronchi and lungs of healthy rats during prolonged inhalation of antibacterial compounds].
    Kulik NM; Nesterov EN
    Antibiotiki; 1971 Jun; 16(6):546-8. PubMed ID: 5112492
    [No Abstract]   [Full Text] [Related]  

  • 23. EXPERIMENTAL SIDEROBLASTIC ANAEMIA.
    HARRISS EB; MACGIBBON BH; MOLLIN DL
    Br J Haematol; 1965 Jan; 11():99-106. PubMed ID: 14247479
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sideroblastic anemia].
    Hilt M; Păcurariu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(1):19-30. PubMed ID: 242054
    [No Abstract]   [Full Text] [Related]  

  • 25. [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid].
    Uçak D; Uçak A
    Tip Fak Mecm; 1969; 32(1):48-52. PubMed ID: 5398987
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modification of side effects from tuberculostatic agents by metoclopramide].
    Pollack KP
    Ther Ggw; 1967 Dec; 106(12):1606 passim. PubMed ID: 5622114
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of drug intolerance to antituberculosis chemotherapy.
    Neff TA; Coan BJ
    Dis Chest; 1969 Jul; 56(1):10-2. PubMed ID: 5789831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid].
    Yoshimoto S; Takeuchi M; Tada A
    Rinsho Ketsueki; 1992 Jul; 33(7):986-90. PubMed ID: 1507421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
    SZENDROEI Z; CSERNUS A
    Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677
    [No Abstract]   [Full Text] [Related]  

  • 30. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 31. [SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
    KITAMOTO O
    Kekkaku; 1963 Aug; 38():348-71. PubMed ID: 14046681
    [No Abstract]   [Full Text] [Related]  

  • 32. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 33. [A severe side effect of antitubercular therapy: pyrazinamide induced thrombocytopenia].
    Roseau JB; Berard H; N'guyen Huy Thuy G; Rocher F; Legodec J; Chouaid C
    Rev Mal Respir; 2008 Nov; 25(9):1142-4. PubMed ID: 19106913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 35. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of different factors on the tolerance of antibacterial preparations by patients with pulmonary tuberculosis].
    Oĭfebakh MI; Simonian LK
    Probl Tuberk; 1970; 48(8):23-6. PubMed ID: 5496734
    [No Abstract]   [Full Text] [Related]  

  • 37. [Frequency of side-effects of tuberulostatics and its relation to the applied combination].
    Bethge W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 39. [Eosinophilic infiltrations of the lung as a radiologic manifestation of hypersensitivity to streptomycin, PAS and INH].
    Furman Z
    Gruzlica; 1967 Jan; 35(1):65-9. PubMed ID: 6044451
    [No Abstract]   [Full Text] [Related]  

  • 40. [UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
    ALBRECHT KF
    Urologe; 1964 Jan; 3():33-7. PubMed ID: 14160920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.